Similar articles for PMID: 29531106

Year	Number of Results
2004	1
2006	3
2007	8
2008	4
2009	9
2010	6
2011	11
2012	12
2013	5
2014	4
2015	5
2016	5
2017	5
2018	5
2019	5
2020	5
2021	3
2022	2
2023	1
2024	3
2025	0

1

The Relationship Between Oseltamivir and Suicide in Pediatric Patients.

Harrington R, Adimadhyam S, Lee TA, Schumock GT, Antoon JW. Harrington R, et al. Ann Fam Med. 2018 Mar;16(2):145-148. doi: 10.1370/afm.2183. Ann Fam Med. 2018. PMID: 29531106 Free PMC article.

2

The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza.

Casscells SW, Granger E, Kress AM, Linton A. Casscells SW, et al. Int J Adolesc Med Health. 2009 Jan-Mar;21(1):79-89. doi: 10.1515/ijamh.2009.21.1.79. Int J Adolesc Med Health. 2009. PMID: 19526698

3

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.

Smith JR, Sacks S. Smith JR, et al. Int J Clin Pract. 2009 Apr;63(4):596-605. doi: 10.1111/j.1742-1241.2009.02010.x. Int J Clin Pract. 2009. PMID: 19335705

4

Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D. Toovey S, et al. Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006. Drug Saf. 2008. PMID: 19026027 Review.

5

The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.

Blumentals WA, Song X. Blumentals WA, et al. MedGenMed. 2007 Oct 30;9(4):23. MedGenMed. 2007. PMID: 18311373 Free PMC article.

6

Adolescent jump case in Japan associated with influenza but not oseltamivir.

Terada K, Kawai Y, Monju A, Wakabayashi T, Ouchi K. Terada K, et al. Pediatr Infect Dis J. 2008 Jan;27(1):88-9. doi: 10.1097/INF.0b013e31815c89ec. Pediatr Infect Dis J. 2008. PMID: 18162953 No abstract available.

7

Safety profile of oseltamivir during the 2009 influenza pandemic.

Donner B, Bader-Weder S, Schwarz R, Peng MM, Smith JR, Niranjan V. Donner B, et al. Pharmacoepidemiol Drug Saf. 2011 May;20(5):532-43. doi: 10.1002/pds.2136. Pharmacoepidemiol Drug Saf. 2011. PMID: 21448900

8

ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.

L'Huillier AG, Ing Lorenzini K, Crisinel PA, Rebsamen MC, Fluss J, Korff CM, Barbe RP, Siegrist CA, Dayer P, Posfay-Barbe KM, Desmeules JA; H1N1 Pediatric Epidemiology Study Group of Geneva. L'Huillier AG, et al. Pharmacogenomics. 2011 Oct;12(10):1493-501. doi: 10.2217/pgs.11.91. Epub 2011 Sep 8. Pharmacogenomics. 2011. PMID: 21902503

9

Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study.

Kang HR, Jang SC, Shin JY. Kang HR, et al. Expert Opin Drug Saf. 2021 Feb;20(2):245-253. doi: 10.1080/14740338.2021.1850690. Epub 2020 Dec 31. Expert Opin Drug Saf. 2021. PMID: 33183123

10

Oseltamivir: cutaneous and neurological adverse effects in children.

[No authors listed] [No authors listed] Prescrire Int. 2006 Oct;15(85):182-3. Prescrire Int. 2006. PMID: 17128526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 29531106

93 results

Results by year